News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Daily News Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI L.A. McKeown October 24, 2022
News Daily News Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events Yael L. Maxwell October 24, 2022
News Daily News Cardiopulmonary Tests in Long COVID Offer Some Clues, Pose More Questions L.A. McKeown October 21, 2022
News Features ‘Ridiculous’ System Has Many Calling for an Interventional Cardiology Match Yael L. Maxwell October 19, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Features From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine L.A. McKeown October 18, 2022
News Daily News STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF Shelley Wood October 17, 2022
News Daily News FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs Michael O'Riordan October 17, 2022
News Daily News Career Flexibility Benefits Cardiologists, Patients Alike: ACC Report Caitlin E. Cox October 13, 2022
News Daily News Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion L.A. McKeown October 13, 2022
News Conference News EACTS 2022 Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG Michael O'Riordan October 12, 2022
News Daily News Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED Yael L. Maxwell October 12, 2022
News Daily News COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review Todd Neale October 12, 2022
News Daily News Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks Michael O'Riordan October 07, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News COAPT Risk Score Useful in Predicting Outcomes in Functional MR Michael O'Riordan October 05, 2022
News Daily News Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use L.A. McKeown October 05, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022